Skip to Main content Skip to Navigation

Acinetobacter spp. et réservoir de gènes de carbapénèmases

Abstract : Carbapenem resistance in Acinetobacter baumannii is increasingly reported and leads to difficult-to-treat nosocomial infections. Carbapenem-hydrolyzing class D b-lactamases (CHDLs) represent the main mechanism of resistance to carbapenems in Acinetobacter spp. The origin (reservoir) of those CHDL genes remains unknown. We identified Acinetobacter radioresistens as the reservoir of the blaOXA-23-like genes currently emerging as the sources of carbapenem resistance in A. baumannii worldwide. Acinetobacter lwoffii was found to be a reservoir of a novel type of CHDL-encoding gene: blaOXA-134. We described the naturally-occurring CHDLs from Acinetobacter johnsonii, Acinetobacter calcoaceticus and Acinetobacter haemolyticus, respectively named OXA-211, OXA-213 et OXA-214. We reported an in vivo selection of reduced susceptibility to carbapenems in A. baumannii. This reduced susceptibility to carbapenems was related to selection of the ISAba1-related overexpression of the naturrally-occurring blaOXA-51/-69 gene from A. baumannii. We identified the novel insertion sequence ISAba9 as being involved in blaOXA-51/-69 gene overexpression, thus contributing to carbapenem resistance in A. baumannii.We reported the first identification of the metallo-b-lactamase VIM-4 determinant in Acinetobacter spp.
Complete list of metadatas
Contributor : Abes Star :  Contact
Submitted on : Thursday, October 18, 2012 - 1:01:18 AM
Last modification on : Friday, October 23, 2020 - 5:04:28 PM
Long-term archiving on: : Saturday, January 19, 2013 - 3:36:12 AM


Version validated by the jury (STAR)


  • HAL Id : tel-00743039, version 1



Samy Figueiredo. Acinetobacter spp. et réservoir de gènes de carbapénèmases. Médecine humaine et pathologie. Université Paris Sud - Paris XI, 2011. Français. ⟨NNT : 2011PA114823⟩. ⟨tel-00743039⟩



Record views


Files downloads